These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38946173)

  • 1. Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy.
    Zhang J; Chen M; Yang Y; Liu Z; Guo W; Xiang P; Zeng Z; Wang D; Xiong W
    J Cell Physiol; 2024 Nov; 239(11):e31349. PubMed ID: 38946173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significant role of amino acid metabolic reprogramming in cancer.
    Liu X; Ren B; Ren J; Gu M; You L; Zhao Y
    Cell Commun Signal; 2024 Jul; 22(1):380. PubMed ID: 39069612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
    Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
    Cancer Lett; 2024 Aug; 597():217076. PubMed ID: 38906524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids.
    Pranzini E; Pardella E; Paoli P; Fendt SM; Taddei ML
    Trends Cancer; 2021 Aug; 7(8):682-699. PubMed ID: 33736962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
    Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
    Bahrambeigi S; Shafiei-Irannejad V
    Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy.
    Zois CE; Harris AL
    J Mol Med (Berl); 2016 Feb; 94(2):137-54. PubMed ID: 26882899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncology Therapeutics Targeting the Metabolism of Amino Acids.
    Muhammad N; Lee HM; Kim J
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
    Allison KE; Coomber BL; Bridle BW
    Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.
    Yang L; Chu Z; Liu M; Zou Q; Li J; Liu Q; Wang Y; Wang T; Xiang J; Wang B
    J Hematol Oncol; 2023 Jun; 16(1):59. PubMed ID: 37277776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.
    Liu Q; Luo Q; Halim A; Song G
    Cancer Lett; 2017 Aug; 401():39-45. PubMed ID: 28527945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review.
    Wang D; Wan X
    Biomed Pharmacother; 2022 Dec; 156():113923. PubMed ID: 36411616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered metabolism in cancer: insights into energy pathways and therapeutic targets.
    Tufail M; Jiang CH; Li N
    Mol Cancer; 2024 Sep; 23(1):203. PubMed ID: 39294640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications.
    Taneja N; Chauhan A; Kulshreshtha R; Singh S
    Life Sci; 2024 Sep; 352():122890. PubMed ID: 38971364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid metabolism in tumor: New shine in the fog?
    Qiu H; Shao N; Liu J; Zhao J; Chen C; Li Q; He Z; Zhao X; Xu L
    Clin Nutr; 2023 Aug; 42(8):1521-1530. PubMed ID: 37321900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship.
    Netea-Maier RT; Smit JWA; Netea MG
    Cancer Lett; 2018 Jan; 413():102-109. PubMed ID: 29111350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.